Dr. Kowalski, JDFR president and CEO, recognized research being done by Dr. Klearchos Papas and Dr. Robert Johnson. Drs. Papas and Johnson are with the University of Arizona in Tucson, and are developing groundbreaking cell therapies to cure T1D through two projects: “High Cell Density, Oxygen Enabled, Beta Cell Encapsulation” and “Accelerated Insulin Absorption Through Miniature Implantable Devices.” Representing the most advanced progress toward curing T1D, these projects are building on insights gained from JDRF research on cell therapies, such as encapsulation.
For more information, see Local T1D research happening here in Arizona!